Belhaven Biopharma | Finanzwire

Basculer en Français

11259	Companies
250096	Keywords
178543	Articles
135996	Press releases

Home
Companies
Belhaven Biopharma

BRIEF

published on 07/09/2024 at 17:05, 2 years 3 months ago

Belhaven Biopharma Study Shows Promising Results for Nasal Epinephrine Delivery

Belhaven Biopharma Nasdepi Anaphylaxis Treatment Medical Research Nasal Epinephrine
PRESS RELEASE

published on 07/09/2024 at 17:00, 2 years 3 months ago

New Canine Study From Belhaven Biopharma Supports Dry Powder Nasal Epinephrine Delivery Solution
Belhaven Biopharma presents promising results of Nasdepi Canine Study at Respiratory Drug Delivery 2024, indicating faster & effective treatment for anaphylaxis. Intranasal dry powder epinephrine offers breakthrough prospects in emergency care for severe allergies

Belhaven Biopharma Anaphylaxis Treatment Nasdepi Canine Study Dry Powder Nasal Solution Respiratory Drug Delivery 2024
PRESS RELEASE

published on 02/08/2024 at 18:30, 2 years 8 months ago

Belhaven Biopharma Announces Groundbreaking Clinical Results for Nasdepi, the Revolutionary Nasal Dry Powder Epinephrine Product
Belhaven Biopharma shares positive results from Phase 1 clinical trial of Nasdepi, a nasal dry powder epinephrine device for treating anaphylaxis. Successful investor round and Series A financing on the horizon

Phase 1 Clinical Trial Series A Financing Belhaven Biopharma Nasdepi Anaphylaxis Treatment
PRESS RELEASE

published on 11/28/2023 at 19:30, 2 years 11 months ago

Belhaven Biopharma Achieves Significant Milestones in Advancing Nasdepi - a Revolutionary Nasal Dry Powder Epinephrine Product

Accesswire

Published on 11/03/2026 at 05:45, 18 minutes ago

Date of Board Meeting
Published on 11/02/2026 at 23:15, 6 hours 48 minutes ago

ATHA Energy Announces Issuance of Common Shares in Satisfaction of US$25 Million Convertible Debenture Interest Payment Obligations
Published on 11/02/2026 at 22:30, 7 hours 33 minutes ago

Sparton Files Morrison Mine N-I 43-101 Technical Report
Published on 11/02/2026 at 17:00, 13 hours 3 minutes ago

PPX Mining Initiates Operating Permit Process for Igor Processing Plant
Published on 11/02/2026 at 17:00, 13 hours 3 minutes ago

QNX Launches Global Developer Hackathon with $50,000 in Prizes to Accelerate Innovation in Mission-Critical Systems

View all ACCESSWIRE

EQS Group

Published on 11/03/2026 at 03:30, 2 hours 33 minutes ago

ADTRAN Holdings, Inc. reports third quarter 2026 financial results
Published on 11/03/2026 at 03:25, 2 hours 37 minutes ago

How President Xi Jinping Has Charted the Course for Boosting China's Strength in Finance: Pursuing a Path of Financial Development with Chinese Characteristics
Published on 11/03/2026 at 02:55, 3 hours 7 minutes ago

WESCAN GOLDFIELDS ANNOUNCES ENGAGEMENT OF RED CLOUD SECURITIES FOR LIQUIDITY SERVICES
Published on 11/02/2026 at 23:11, 6 hours 51 minutes ago

EQS-Adhoc: HUGO BOSS AG: HUGO BOSS UPDATES ITS FULL YEAR 2026 OUTLOOK
Published on 11/02/2026 at 22:05, 7 hours 58 minutes ago

Abivax to Participate in Upcoming Fall Investor Conferences

Les Echos

Published on 11/02/2026 at 21:08, 8 hours 54 minutes ago

GROUPE SFPI LIQUIDIDY CONTRAT H1 2026
Published on 11/02/2026 at 18:30, 11 hours 33 minutes ago

Disclosure of transactions in own shares from October 26 to October 30, 2026
Published on 11/02/2026 at 18:17, 11 hours 45 minutes ago

Reporting on share buyback transactions carried out between October 28 and October 29, 2026
Published on 11/02/2026 at 18:00, 12 hours 3 minutes ago

Covivio - Information on total number of voting rights and share capital
Published on 11/02/2026 at 17:59, 12 hours 3 minutes ago

Saint-Gobain completes the divestment of its Dahl specialist distribution business in Sweden, Norway and Denmark

View all LES ECHOS COMFI WIRE